Global Clinical Trials Market Trends, Developments and Key Players
FAQ's
Answer : According to Precedence Research, the stroke diagnostic and therapeutic market size was estimated at USD 32.69 billion in 2021 and is anticipated to reach over USD 65.45 billion by 2030.
Answer : The global stroke diagnostic and therapeutic market is representing impressive CAGR of 8% during the forecast period 2022 to 2030.
Answer : The diagnostics segment is estimated hold largest revenue share in the forecast period of time 2021-2030.
Answer : The key companies functioning in the worldwide stroke diagnostic and therapeutic are Neural Analytics, Cordis Corporation, Cerebrotech Medical Systems, Inc. Koninklijke Philips N.V. Medtronic plc. Boston Scientific Corporation, GE Healthcare, Medfield Diagnostics, Samsung Neurologica, NIRX, Gowerlabs, Siemens AG, Genentech Inc. Merck & Co., Inc. Hyperfine MRI, Stryker Corporation, Abbott Laboratories among others.
Answer : Increasing number of patients at risk of increasing stroke across the globe is major factor driving growth of the global stroke diagnostics and therapeutic market. Increasing prevalence of high blood pressure among the population across the globe which is a key risk factor fuelling patients developing stroke at risk.
Answer : On the basis of application, ischemic stroke segment accounted for the largest revenue with weighty share in 2020 as ischemic stroke is the most usual type of stroke which is caused by a blood clot that blocks a blood vessel in the brain.
Get a Sample of this Report
Global Clinical Trials Market
